Tetrandrine Tablets Used in Hospitalized Adults With COVID-19
Status:
Not yet recruiting
Trial end date:
2024-12-12
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the effectiveness of tetrandrine tablets
in preventing the progression of COVID-19 from severe to critical.